Exploring mechanisms of protein influence on calcium oxalate kidney stone formationUrolithiasis - Tập 49 - Trang 281-290 - 2021
Garrett K. Berger, Jessica Eisenhauer, Andrew Vallejos, Brian Hoffmann, Jeffrey A. Wesson
Calcium oxalate monohydrate (COM) crystals are the primary constituent of most kidney stones, but urine proteins in stone matrix are believed to be critical elements for stone formation from these crystals. Recent data have shown that hundreds of proteins appear in the stone matrix with no explanation for inclusion of so many proteins. We have proposed a stone formation model with protein stimulat...... hiện toàn bộ
Micro-percutaneous nephrolithotomy in infants: a single-center experienceUrolithiasis - - 2015
Onur Dede, Ahmet Ali Sancaktutar, Okan Baş, Mansur Dağgüllu, Mazhar Utangaç, Necmettin Penbegul, Haluk Soylemez, Namık Kemal Hatipoglu, Mehmet Nuri Bodakci, Yaşar Bozkurt, Murat Atar, Gülay Dede
This study aimed to investigate the effectiveness and reliability of micro-percutaneous nephrolithotomy (micro-PNL) for the management of kidney stones in pediatric patients. This retrospective study included 24 infants that underwent micro-PNL for renal stones between March 2012 and April 2015. The inclusion criteria included: age younger than 2 years, stone size <20 mm, absence of urinary tract ...... hiện toàn bộ
Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stonesUrolithiasis - Tập 41 - Trang 315-322 - 2013
Dawn F. Wolfgram, Vinod Gundu, Brad C. Astor, R. Allan Jhagroo
Prevention of recurrent calcium stone disease includes treatment with thiazide and thiazide-type diuretics to reduce urinary calcium (UCa) levels, with the reduction in UCa correlating with risk of stone recurrence. There has been a recent trend of using lower doses of these medications and change from chlorthalidone (CTL) use to hydrochlorothiazide (HCTZ) use. It is unknown whether low doses of H...... hiện toàn bộ
Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)Urolithiasis - Tập 51 - Trang 1-9 - 2023
David S. Goldfarb, John C. Lieske, Jaap Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak
Nedosiran is an N-acetyl-D-galactosamine (GalNAc)–conjugated RNA interference agent targeting hepatic lactate dehydrogenase (encoded by the LDHA gene), the putative enzyme mediating the final step of oxalate production in all three genetic subtypes of primary hyperoxaluria (PH). This phase I study assessed the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneous nedosiran in p...... hiện toàn bộ
Bone mineral density in adolescent urinary stone formers: is sex important?Urolithiasis - Tập 48 - Trang 329-335 - 2020
Kirsten Kusumi, Andrew L. Schwaderer, Curtis Clark, Kevin Budge, Nazar Hussein, Rupesh Raina, Michelle Denburg, Fayez Safadi
Urinary stone disease (USD) is affecting a greater number of children and low bone mineral density (BMD) and increased skeletal fractures have been demonstrated in stone patients; however, the mechanism(s) driving bone disease remain unclear. This pilot study was undertaken to assess an adolescent kidney stone cohort’s BMD and evaluate for an inverse correlation between BMD and urine concentration...... hiện toàn bộ